U.S. Wireless Telecom Stock News

BeOne Medicines (ONC) is back in focus after InSysBio extended its collaboration with the company to apply mechanistic translational modeling, aimed at refining dose selection and clinical study design in oncology programs. See our latest analysis for BeOne Medicines. That extended collaboration and a run of supportive analyst commentary have come alongside firm share price momentum. A 1 month share price return of 6.01% and a 1 year total shareholder return of 58.35% signal strong recent...

Strattec Security (STRT) opened its Q2 2026 scorecard with revenue of US$137.5 million and basic EPS of US$1.21, while trailing twelve month revenue stood at US$586.0 million and EPS at US$6.70, setting a clear earnings baseline for investors. Over recent quarters, the company has seen revenue move from US$129.9 million and EPS of US$0.33 in Q2 2025 to US$137.5 million and EPS of US$1.21 in Q2 2026, with intermediate quarters at US$144.1 million, US$152.0 million and US$152.4 million helping...

JetBlue Airways (NasdaqGS:JBLU) has entered an interline partnership with Contour Airlines, connecting their networks across more than 100 destinations. The agreement is designed to give travelers a single itinerary across both carriers, including through-ticketing and coordinated schedules. JetBlue has also revealed its first special aircraft livery honoring Dominican heritage, focused on the Dominican Republic and Dominican communities. For you as an investor watching NasdaqGS:JBLU, this...

Liquidity Services (LQDT) opened Q1 2026 with revenue of about US$121.2 million and basic EPS of US$0.24, setting the tone with headline numbers that build on its recent earnings progress. Over the past five reported quarters, the company has seen revenue move between roughly US$106.9 million and US$122.3 million, while quarterly basic EPS ranged from about US$0.19 to US$0.25, with trailing twelve month EPS at roughly US$0.96. That backdrop of steady topline and earnings, alongside an...

Earnings snapshot and context Suburban Propane Partners (SPH) opened fiscal Q1 2026 with revenue of US$370.4 million and basic EPS of US$0.69, putting fresh numbers on the table for investors tracking its income focused story. The company has seen revenue move from US$373.3 million in Q1 2025 to US$370.4 million in Q1 2026, while basic EPS shifted from US$0.30 to US$0.69 over the same period, with trailing twelve month EPS at US$2.03 on revenue of about US$1.4 billion. Overall, the latest...

Silgan Holdings Inc. has reported its fourth-quarter and full-year 2025 results, with quarterly sales rising to US$1,468.6 million but net income falling to US$18.2 million, while full-year sales increased to US$6.48 billion and net income edged up to US$288.4 million. Beneath the headline numbers, Silgan’s adjusted earnings, strong cash generation, and the successful integration of recent packaging acquisitions underscore growing importance of its higher-value dispensing and specialty...

Ladder Capital (LADR) has wrapped up FY 2025 with fourth quarter total revenue of US$50.5 million and basic EPS of US$0.13, capping a year in which quarterly revenue ranged from US$51.0 million to US$57.6 million and EPS moved between US$0.09 and US$0.15. Over the past six reported quarters, total revenue has stayed in a band of roughly US$50 million to US$68.6 million while basic EPS has moved between US$0.09 and US$0.25, giving investors a clear view of how earnings have tracked alongside a...

Vertex (VERX) is back in focus after publishing its 2025 End-of-Year U.S. Sales Tax Rates and Rules Report, highlighting record sales tax changes across more than 12,000 jurisdictions and a rare increase in average state rates. See our latest analysis for Vertex. The report lands after a volatile stretch for Vertex, with a 1-day share price return of 5.22% to US$15.73 coming against a 30-day share price return of 21.27% and a 1-year total shareholder return of 72.31%. Overall, short term...

Procore Technologies (PCOR) has put fresh attention on its stock after its Procore for Government platform received FedRAMP Moderate Authorization and the company acquired Datagrid to deepen its AI capabilities in construction software. See our latest analysis for Procore Technologies. Despite the FedRAMP approval and the Datagrid acquisition, Procore's recent share price performance has been weak, with a 30 day share price return of a 31.27% decline and a 1 year total shareholder return of a...

Why Reddit’s Q4 earnings are back in focus Reddit (RDDT) is back on investor radars after fourth quarter results topped revenue and profit expectations, coupled with Q1 guidance above forecasts and a new US$1b share repurchase plan. See our latest analysis for Reddit. Even with the strong Q4 release, investors have been reassessing Reddit’s risk and growth profile. The 30 day share price return shows a 45.27% decline and the 1 year total shareholder return shows a 37.92% decline from the...

Somnigroup International (NYSE:SGI) has announced an upcoming Investor Day event. Executive management is expected to outline the company’s vision, growth initiatives, and multi year financial targets. The event is aimed at providing greater clarity on strategy and capital allocation for shareholders and potential investors. Somnigroup International, trading at $96.32, has drawn attention with a 50.7% return over the past year and 211.8% over the past five years. In the shorter term, the...

Dell Technologies (DELL) stock is back in focus after a fresh leadership move in Asia Pacific, Japan & Greater China, along with new partner incentives and steady AI infrastructure demand reshaping expectations. See our latest analysis for Dell Technologies. The leadership reshuffle in Asia Pacific and refreshed partner incentives arrive as Dell’s share price has climbed 4.91% over the last day and 5.78% over the past week. The 1-year total shareholder return of 15.91% contrasts with weaker...

WEX Inc. has already reported fourth-quarter 2025 results, with revenue rising to US$672.9 million and net income to US$84.3 million, while issuing 2026 revenue guidance of US$2.70 billion to US$2.76 billion and first-quarter 2026 guidance of US$650 million to US$670 million. The company’s Benefits and Corporate Payments segments helped drive the earnings beat, but management’s 2026 outlook was restrained, reflecting expectations for lower U.S. retail fuel prices. We’ll now examine how this...

VeriSign (VRSN) has just closed out FY 2025 with fourth quarter revenue of US$425.3 million and basic EPS of US$2.23, rounding out a year in which trailing twelve month revenue came in at US$1.66 billion and EPS at US$8.83. Over the past six quarters, revenue has moved from US$390.6 million in Q3 2024 to US$425.3 million in Q4 2025, while quarterly basic EPS has ranged between US$2.00 and US$2.28, setting the backdrop for trailing net income of US$825.7 million. With net margins staying high...

If you are wondering whether U.S. Physical Therapy is fairly priced or offering room for value, this article is designed to walk you through what the current numbers suggest. The share price recently closed at US$85.58, with returns of 2.0% over 7 days, 7.7% over 30 days, 8.5% year to date, 0.6% over 1 year, a 7.5% decline over 3 years, and a 32.5% decline over 5 years. These mixed return figures sit against a backdrop of ongoing interest in outpatient physical therapy providers in the U.S...

Recent analyst reports on Park Hotels & Resorts (PK) arrived almost back to back, with JP Morgan, Barclays and Truist Securities outlining contrasting views as the company refocuses on domestic assets and refinances upcoming debt. See our latest analysis for Park Hotels & Resorts. The recent 3.2% 1-day and 8.2% 30-day share price returns suggest short term momentum is picking up, even though the 1-year total shareholder return of a 4.1% decline and 5-year total shareholder return of a 16.8%...

Accenture Federal Services, part of NYSE:ACN, has been selected to play a major role in the U.S. Department of Veterans Affairs Electronic Health Record Modernization program. The multi year engagement centers on transforming the healthcare system that serves millions of U.S. veterans through new electronic health record capabilities. Accenture will provide integration and transformation services focused on digital government and healthcare modernization. For you as an investor, this puts...

WisdomTree (NYSE:WT) is expanding its blockchain efforts with regulated tokenized funds now launched on the Solana network. The company is positioning tokenized assets and digital infrastructure as a core part of its business model, beyond traditional ETFs. These moves extend its earlier work in digital assets into a broader push to integrate blockchain with mainstream financial services. For you as an investor, this matters because WisdomTree is not just an ETF issuer anymore; it is...

Nathan's Famous (NATH) has reported Q3 2026 revenue of US$34.3 million with basic EPS of US$0.75, putting the latest quarter against a year when trailing twelve month EPS stands at US$5.24 on revenue of US$157.8 million. Over the past few quarters, the company has seen revenue range from US$30.8 million to US$47.0 million, while basic EPS has moved between roughly US$0.75 and US$2.18, giving investors a clear view of how earnings track against the top line. With a net profit margin of 13.6%...

In late January 2026, The Trade Desk appointed long-time insider Tahnil Davis as interim CFO after Alexander Kayyal’s brief five‑month tenure, while partner Xumo announced new advertiser access to its more than 60 million monthly active streaming users via The Trade Desk’s OpenPath connection through FreeWheel. Together, the abrupt finance leadership change and Xumo’s move to simplify direct access to connected TV inventory highlight the tension between governance stability and product reach...

Health Canada has approved Merck's ENFLONSIA (clesrovimab), a monoclonal antibody for the prevention of respiratory syncytial virus (RSV) in newborns and infants. The decision gives Canadian clinicians a new tool aimed at reducing RSV related illness in a highly vulnerable pediatric group. For investors watching Merck (NYSE:MRK), this approval adds a fresh product to the company's vaccines and biologics portfolio at a time when the stock trades around $121.93. Shares have returned 10.6%...

Recent trading context for Marzetti Marzetti (MZTI) has caught investor attention after a recent stretch of mixed returns, with the share price roughly flat over the past day but negative over the past week, month, and past 3 months. See our latest analysis for Marzetti. Zooming out, Marzetti’s share price has slipped over the past week, month and quarter, and its 1 year total shareholder return of 16.18% decline points to pressure building over a longer stretch. This may reflect shifting...

Health Canada approval puts Yorvipath in focus for Ascendis investors Ascendis Pharma (NasdaqGS:ASND) just received market authorization from Health Canada for Yorvipath, its parathyroid hormone replacement therapy for adults with chronic hypoparathyroidism, bringing a new regulated market into the picture for shareholders. See our latest analysis for Ascendis Pharma. At a share price of $222.15, Ascendis Pharma has seen a 12.34% 90 day share price return and an 83.79% one year total...

AutoNation (AN) has put up a mixed FY 2025 finish, with Q4 revenue at US$6.9b, basic EPS of US$4.70 and net income of US$172.1m, set against trailing twelve month revenue of US$27.6b and EPS of US$17.04. Over recent quarters the company has seen quarterly revenue move from US$7.0b in Q2 2025 to US$6.9b in Q4 2025. Quarterly basic EPS shifted from US$2.29 in Q2 to US$5.72 in Q3 and US$4.70 in Q4, giving investors plenty to weigh up around earnings power and sales momentum. With trailing net...